CARGO Therapeutics Inc. C... (CRGX)
NASDAQ: CRGX
· Real-Time Price · USD
4.54
0.08 (1.79%)
At close: Aug 15, 2025, 3:59 PM
4.54
-0.11%
After-hours: Aug 15, 2025, 04:04 PM EDT
CARGO Therapeutics Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Revenue | n/a | n/a | 7.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 572K | 1.22M | 1.36M | 1.77M | 2.06M | 1.85M | 1.1M | 1.09M | n/a | n/a | 430K | 353K |
Gross Profit | -572K | -1.22M | -1.36M | -1.77M | -2.06M | -1.85M | -1.1M | -1.09M | n/a | n/a | -430K | -353K |
Operating Income | -52.9M | -88.42M | -50.13M | -47.11M | -49.32M | -40.81M | -34.96M | -28.71M | -17.8M | -15.25M | -11.01M | -10.05M |
Interest Income | 3.27M | 3.94M | 4.67M | 5.4M | 4.99M | 5M | n/a | 894K | 578K | 105K | n/a | n/a |
Pretax Income | -49.94M | -84.5M | -45.44M | -41.91M | -44.35M | -35.81M | -32.08M | -35.47M | -17.85M | -12.75M | -13.75M | -12.29M |
Net Income | -49.94M | -84.5M | -45.44M | -41.91M | -44.35M | -35.81M | -32.08M | -35.47M | -17.85M | -12.75M | -13.75M | -12.29M |
Selling & General & Admin | 8.29M | 11.51M | 10.63M | 11.18M | 11.86M | 10.3M | 4.2M | 2.79M | 3.87M | 2.69M | 1.77M | 1.23M |
Research & Development | 7.51M | 30.64M | 39.5M | 35.93M | 37.46M | 30.5M | 27.07M | 22.23M | 13.93M | 12.56M | 9.23M | 8.47M |
Other Expenses | 37.1M | 46.28M | -1.36M | n/a | -2.06M | -1.85M | 2.59M | 2.6M | 49K | -138K | -6K | n/a |
Operating Expenses | 52.9M | 88.42M | 48.77M | 47.11M | 47.26M | 38.95M | 33.85M | 27.62M | 17.8M | 15.25M | 11.01M | 9.7M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.6M | 2.71M | 1.46M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 52.9M | 88.42M | 50.13M | 47.11M | 49.32M | 40.81M | 34.96M | 28.71M | 17.8M | 15.25M | 11.01M | 10.05M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -10K | n/a | n/a | 49K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 48.13M | 47.85M | 46.04M | 47.66M | 43.34M | 41M | 41.21M | 38.67M | 38.67M | 38.67M | 28.95M | 19.47M |
Shares Outstanding (Diluted) | 48.13M | 47.85M | 46.04M | 47.66M | 43.34M | 41M | 41.21M | 38.67M | 38.67M | 38.67M | 28.95M | 19.47M |
EPS (Basic) | -1.04 | -1.77 | -0.99 | -0.88 | -1.02 | -0.87 | -0.78 | -0.92 | -0.46 | -0.33 | -0.47 | -0.63 |
EPS (Diluted) | -1.04 | -1.77 | -0.99 | -0.88 | -1.02 | -0.87 | -0.78 | -0.92 | -0.46 | -0.33 | -0.47 | -0.63 |
EBITDA | -15.23M | -40.92M | -44.07M | -40.12M | -42.27M | -33.96M | -30.98M | -34.38M | -16.99M | -14.6M | -10.61M | -9.7M |
EBIT | -15.8M | -42.15M | -45.44M | -41.91M | -44.35M | -35.81M | -32.08M | -35.47M | -17.85M | -11.14M | -11.04M | -10.83M |
Depreciation & Amortization | 572K | 1.22M | 1.36M | 1.78M | 2.07M | 1.85M | 1.1M | 1.09M | 859K | 683K | 430K | 353K |